Third Arc Bio

Clinical-stage multispecific antibody engineering platform for best-in-class oncology and immunology therapies

a16zActive

What they do

Problem

Current cancer and immune disease treatments often lack sufficient specificity and efficacy, leading to limited clinical benefit and toxicity.

Solution

A clinical-stage multispecific antibody engineering platform to develop best-in-class antibody therapeutics for oncology and immunology.

Who it's for

Oncologists and immunologists treating patients via hospitals and specialty clinics that prescribe biologic therapeutics.